Marie Bouillez

Syndicate One is an international network-driven fund making early-stage investments into high-potential Belgium-based and Belgian-founded tech startups. Syndicate One pools valuable expertise, a vast international network, and smart seed capital from an impressive group of experienced founders, operators and professional investors to help young Belgian startups reach the next level. Additionally, Syndicate One frequently launches targeted initiatives to strengthen Belgium’s tech ecosystem, such as the first standardised convertible note agreement fit for the Belgian market, the ‘State of Belgian Tech Report’, and industry events. In its first four years, Syndicate One has invested in two unicorns, Aikido Security and Fundamental, as well as high-growth companies like Techwolf, Conveo, Sirona Technologies, Donna, Tekst, Cosmic Aerospace, Powernaut, SAPI, Mindoo and other promising startups.

A6K is a multidisciplinary center that collocates industrial companies, start-ups, research centers, institutional partners and training programs. We provide an exceptional environment to empower collaborative growth on themes such as energy, communication, and industry 4.0 to encourage synergies and the emergence of new projects. We aim to turn Wallonia into a European leading innovation ecosystem in these fields.

Were a Brussels-based start-up studio & incubator. We believe that digital solutions are the answer to a more sustainable, accessible, and better healthcare for everyone. Lets co-create!

PharmaFluidics is a young, dynamic & fast paced tech company based in Ghent, Belgium. As a spin-off of the Vrije Universiteit Brussels, and backed by experienced Venture Capital (Qbic, PMV, Innovation Fund/Essencia, Theodorus), PharmaFluidics has developed a series of game-changing chromatography products. With unprecedented analytical resolution performance, PharmaFluidics’ micro-chip based chromatography cartridges are now being commercialized for cutting-edge bio-marker, diagnostics and drug research & development applications in the global biotech and pharma industries. The key expertise of PharmaFluidics are the design, lithographic production, and surface treatment of silicon wafers for use as separation devices in liquid chromatography. PharmaFluidics collaborates with an extensive network of centers of excellence and pioneer users to develop a broad range of applications.

Antigon SA is an innovative medtech company, spinoff of Free University Brussels (ULB), which aims to improve blood safety transfusion. Ultimate Safety in Transfusion with ISABO™ ISABO™ is a Point-Of-Care Testing (POCT) device able to automatically perform an ABO-D compatibility test at the patient bedside. Moreover ISABO™ also features with an electronic identification system using barcode from patient wristbands and blood bags, ultimately ensuring transfusion safety all the way to bedside. ISABO™ will connect to your information system to exchange transfusion process information and advance digitization of care. Blood compatibility : Ensures the compatibility of blood types of the recipient and the blood to be transfused just before transfusion. Full traceability : Provides full traceability of the entire transfusion process, from ordering the blood bag to registering the actual transfusion. Features : - System for reading of barcodes. - System for identification of users through their RFID badge. - System allowing 2 quick ABO-D grouping tests from blood bag and patient with a disk, and automatically verification of their compatibility at the patient bedside. - Capable to manage minimum 10 patients simultaneously with associated blood bags. - Autonomy of at least 8 hours (in full use) and battery Li-ion, 15 Volts. - Charged and connected to Ethernet via its docking station. - Each change is synchronized with the middleware and applied to all other instruments of the hospital. - Disk stability minimum 12 months. Contact : info@antigon.eu - Phone : +32 (0)470 17 26 91

Digital Attraxion is a digital Startups Accelerator that provides coaching, networking and financial support to realize the value proposition of projects and bring them to the first fundraising. DIGITAL ATTRAXION, set up at the initiative of the Invests (Sambrinvest, IMBC and WAPINVEST) and in partnership with the local project support agencies of Hainaut Belgium (Charleroi, Mons, Tournai), helps all innovative projects to integrate In the local economic ecosystem. More precisely, its objective is the support projects of start-ups being created or newly created, towards their first fundraising. This support takes the form of an intensive coaching by specialized coaches, if necessary supplemented with seed funding to validate the business model with the market and the ability of its team to execute it. Digital Attraxion develops collaborations with corporate actors, in order to be in contact with the needs of the market and to enable the startups to benefit from the experience, market and networks of established companies. Apply now online: www.digital-attraxion.com

Orgenesis is a global biotech company that has been committed to unlocking the potential of decentralized cell and gene therapies (CGTs) since 2012. Orgenesis established the POCare Network in 2020 to bring academia, hospitals, and Industry together to make these innovations more affordable and accessible to patients. In 2022, the POCare Services business unit responsible for developing and managing the decentralized POCare Centers and proprietary OMPULs was formed. Orgenesis will continue to focus on advancing to market through various partnerships its CGTs to provide a rapid, globally harmonized pathway for these therapies to reach and treat large numbers of patients at lowered costs through efficient, scalable, and decentralized production.

CluePoints is the premier provider of RBQM and data quality oversight software. We’re leveraging the potential of AI using advanced statistics and ML to determine the quality, accuracy, and integrity of clinical trial data both during and after the study. Aligned with guidance from the FDA, EMA, ICH, and MHRA, CluePoints supports central and on-site monitoring, medical review, and quality risk management to drive a holistic risk-based strategy. Coupled with thought leadership and consulting expertise to aid risk assessment and solution implementation, the result is positive clinical development outcomes, increased operational efficiency, lower costs, and reduced regulatory submission risk as part of the industry paradigm shift to RBQM. To learn more about CluePoints, visit CluePoints.com.

MaSTherCell is a dynamic and global Contract Development and Manufacturing Organization (CDMO) on a mission to deliver optimized process industrialization capacities to cell therapy organizations and speed up the arrival of their therapies onto the market. MaSTherCell is present in Europe (Gosselies, Belgium) with two plants and in the US (Houston, Texas). At the heart of MaSTherCell is a team of more than 200 highly dedicated experts combining strong experience in cGMP cell therapy manufacturing with a technology-focused approach and a substantial knowledge of the industry. From technology selection to business modeling, GMP manufacturing, process development, quality management, and analytical assay development, MaSTherCell's teams are fully committed to helping their clients fulfill their objective of providing sustainable and affordable therapies to their patients. For more information, visit www.masthercell.com.

Women on Board asbl – vzw Created in December 2009 Objective: to promote access of women to directorship roles in Belgian enterprises, public and private Primary goals: • create a pool of women candidates board members • Introduce the concept of competences and skills • Take action to promote the initiative and facilitate access of Belgian enterprises to this pool. With the financial support of the Federal Ministry and Belgian Institute for The Equality of Women and Men (IEFH/IGVM), of the Region of Wallonia, Brussels Capital and the Flemish Region as well. Women on Board is a non for profit organisation created in December 2009 with the aim to promote female participation on Boards of Directors, important committees and decision-making bodies in small and large Belgian companies in both the public and private sector. The association, founded by five businesswomen (Emmanuèle Attout, Cécile Coune, Marie Evrard, Françoise Roels and Sonja Rottiers) now has a “pool” of more than 330 women with the experience and competence required for Board positions. A further aim of Women on Board is to help companies looking for women board members through facilitating access to this pool, where they can expect to find women with the right profile. Contact : info@womenonboard.be

Syndicate One is an international network-driven fund making early-stage investments into high-potential Belgium-based and Belgian-founded tech startups. Syndicate One pools valuable expertise, a vast international network, and smart seed capital from an impressive group of experienced founders, operators and professional investors to help young Belgian startups reach the next level. Additionally, Syndicate One frequently launches targeted initiatives to strengthen Belgium’s tech ecosystem, such as the first standardised convertible note agreement fit for the Belgian market, the ‘State of Belgian Tech Report’, and industry events. In its first four years, Syndicate One has invested in two unicorns, Aikido Security and Fundamental, as well as high-growth companies like Techwolf, Conveo, Sirona Technologies, Donna, Tekst, Cosmic Aerospace, Powernaut, SAPI, Mindoo and other promising startups.

A6K is a multidisciplinary center that collocates industrial companies, start-ups, research centers, institutional partners and training programs. We provide an exceptional environment to empower collaborative growth on themes such as energy, communication, and industry 4.0 to encourage synergies and the emergence of new projects. We aim to turn Wallonia into a European leading innovation ecosystem in these fields.

We are strong believers in the role that science and innovation can play in solving the problems of both today and tomorrow. 50°North Ventures’ experienced team helps our local disruptive innovators to find growth and become global success of tomorrow. Based in Belgium and Canada, our platform provides two fund families (Theodorus and Seeder Funds) and four dedicated incubators, helping innovators along their way to transform ideas into viable and sustainable solutions. Our unique ecosystem brings together inspiring entrepreneurs and incredible funding opportunities across the miles. Come join us on our journey - and help make a genuine difference.

Early-stage financing and growth capital for Benelux and French digital startups